Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
3 December 2015
Header
Header image
Highlight of the week

The EFPIA DG Lecture - Innovators or Speculators? Price, value and access to medicines in Europe
03 December 2015

This year, the DG Lecture took the format of a conversation between EFPIA DG Richard Bergström and Menno Aarnout, Executive Director of the International Association of Mutual Benefit Societies (AIM), which represents insurers that cover more than 200 million European citizens. The conversation focused on price, value and access to medicines in Europe.

You can watch the recording of the event here.

Read more

News

News

EBE is recruiting a Regulatory Affairs Manager
03 December 2015

About EBE: European Biopharmaceutical Enterprises, EBE, is the European trade association that represents biopharmaceutical companies of all sizes operating in Europe. EBE is a specialised [...] Read more

News

Bulgarian MoU to Boost Patient Access to Innovative Medicines
03 December 2015

EFPIA welcomes the Memorandum of Understanding signed on 1 December 2015, between the Bulgarian Health Ministry and representatives of the pharmaceutical industry, doctors’ and patients’ [...] Read more

From our blog

From our blog

Consumers, doctors and the pharmaceutical industry: more transparency for a healthier relationship (Guest Blog)
02 December 2015 by Ilaria Passarani (BEUC)

If we want patients to trust the medicines they take, to trust the doctors, nurses and other professionals who treat them, it is key that all decisions are made in their best interest. To do so, full transparency is the answer.

Read more

From our blog

Working Together for Patients: Advisory Boards
02 December 2015 by Andrew Powrie-Smith

Over the coming weeks, we will be looking at the types of activity undertaken between the pharmaceutical industry and healthcare professionals; in this case – Advisory Boards.

Read more

Events calendar

Events Calendar

Inaugural Conference of the European Institute for Innovation through Health Data (i~HD)
On 10/03/2016 (Paris, France)

This Inaugural Conference will mark the parallel launch of a novel European platform to support multi-centre clinical research. This operational platform, the result of the European project EHR4CR (Electronic Health Records for Clinical Research), can connect securely to the data within multiple hospital EHR systems and clinical data warehouses across Europe, to enable a trial sponsor to predict the number of eligible patients for a candidate clinical trial protocol, to assess its feasibility and to locate the most relevant hospital sites.

The role of i~HD, as a not-for-profit Institute, is to provide independent governance oversight of such services now, and as these expand to connect with many more hospitals across Europe. The conference will present this platform and its pharma-led adoption programme, and detail the i~HD governance services that reflect state-of-the-art in the trustworthy re-use of health data for research. You will also learn about Europe's largest "big data" project in health: EMIF (European Medical Information Framework). The views of patients on the benefits of reusing their data for research will be presented by Mary Baker, past President of the European Brain Council, one of our keynote speakers.

For more information, please click here

Read more

Events Calendar

Certificate in European Healthcare Compliance Ethics & Regulation
From 11/01/2016 to 14/01/2016 (Paris, France)

PROGRAMME OVERVIEW

The pharmaceutical, biotech and medical device industries increasingly are facing a more challenging regulatory and enforcement landscape throughout Europe. This intensive, multi-day educational and training certification in healthcare compliance addresses the myriad of legal, regulatory and compliance issues faced by pharmaceutical, biotech and medical device manufacturers doing business in Europe. 

Read more

What we are reading

What we are reading

The EFPIA's Richard Bergström says the drug pricing debate is a complex one
02 December 2015 (Pharmafile)

Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions 'would be detrimental not only to the industry, but also to payers and, ultimately, to patients.'

Read more

What we are reading

Top 10 Innovations 2015
02 December 2015 (The Scientist)

This year’s installment of The Scientist’s annual Top 10 Innovations competition highlights a mixture of basic research and clinical tools. Our expert panel of independent judges selected sequencers, reagent kits, genome-editing methods, and other technologies that could have huge impacts on science and medicine alike.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail